Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨

路透中文

Sep 02

BUZZ-Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨

9月2日 - ** 合同研究组织Fortrea（FTRE.O）的股价在盘前交易中上涨1.2%，报17.94美元

** 该公司表示，将通过全现金交易收购Worldwide Clinical Trials的早期阶段服务部门，交易估值约为4500万美元

** 该公司表示，该业务包括位于圣安东尼奥的一家拥有200张床位的临床药理学中心、位于奥斯汀的一家生物分析实验室以及位于得克萨斯州的一家生物样本存储设施

** FTRE表示，此次收购将增强其内部生物分析能力，并扩大其在北美地区的早期临床研究能力

** Worldwide表示，此次交易将使其能够将投资重点放在快速增长的肿瘤学、神经科学、内科及罕见病领域的后期业务上

** 该交易预计将在获得监管机构和许可批准后完成

** 截至上一交易日收盘，该股年初至今累计上涨约3%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2664819637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664819637\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664819637?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-09-02 19:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664819637","market":"us","top_or_hot":-1,"title":"Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨</title></head><body><p><span>9月2日</span><span> - </span>** 合同研究组织Fortrea（<span>FTRE.O</span>）的股价在盘前交易中上涨1.2%，报17.94美元</p><p>** 该公司表示，将通过全现金交易收购Worldwide Clinical Trials的早期阶段服务部门，交易估值约为4500万美元</p><p>** 该公司表示，该业务包括位于圣安东尼奥的一家拥有200张床位的临床药理学中心、位于奥斯汀的一家<a href=\"https://laohu8.com/S/000504\">生物</a>分析实验室以及位于得克萨斯州的一家生物样本存储设施</p><p>** FTRE表示，此次收购将增强其内部生物分析能力，并扩大其在北美地区的早期临床研究能力</p><p>** Worldwide表示，此次交易将使其能够将投资重点放在快速增长的肿瘤学、神经科学、内科及罕见病领域的后期业务上</p><p>** 该交易预计将在获得监管机构和许可批准后完成</p><p>** 截至上一交易日收盘，该股年初至今累计上涨约3%</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-09-02 19:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨</title></head><body><p><span>9月2日</span><span> - </span>** 合同研究组织Fortrea（<span>FTRE.O</span>）的股价在盘前交易中上涨1.2%，报17.94美元</p><p>** 该公司表示，将通过全现金交易收购Worldwide Clinical Trials的早期阶段服务部门，交易估值约为4500万美元</p><p>** 该公司表示，该业务包括位于圣安东尼奥的一家拥有200张床位的临床药理学中心、位于奥斯汀的一家<a href=\"https://laohu8.com/S/000504\">生物</a>分析实验室以及位于得克萨斯州的一家生物样本存储设施</p><p>** FTRE表示，此次收购将增强其内部生物分析能力，并扩大其在北美地区的早期临床研究能力</p><p>** Worldwide表示，此次交易将使其能够将投资重点放在快速增长的肿瘤学、神经科学、内科及罕见病领域的后期业务上</p><p>** 该交易预计将在获得监管机构和许可批准后完成</p><p>** 截至上一交易日收盘，该股年初至今累计上涨约3%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4S44U113:1","article_id":"2664819637","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664819637","pubTimestamp":1788349931,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨9月2日-** 合同研究组织Fortrea（FTRE.O）的股价在盘前交易中上涨1.2%，报17.94美元** 该公司表示，将通过全现金交易收购Worldwide Clinical Trials的早期阶段服务部门，交易估值约为4500万美元** 该公司表示，该业务包括位于圣","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4121":"生命科学工具和服务","FTRE":"Fortrea Holdings Inc."},"translate_title":"Fortrea's stock price rose after it acquired Worldwide Clinical Trials' early Clinical trial services business for $45 million.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FTRE":0.9},"content_text":"BUZZ-Fortrea以4500万美元收购Worldwide Clinical Trials的早期临床试验服务业务后股价上涨9月2日 - ** 合同研究组织Fortrea（FTRE.O）的股价在盘前交易中上涨1.2%，报17.94美元** 该公司表示，将通过全现金交易收购Worldwide Clinical Trials的早期阶段服务部门，交易估值约为4500万美元** 该公司表示，该业务包括位于圣安东尼奥的一家拥有200张床位的临床药理学中心、位于奥斯汀的一家生物分析实验室以及位于得克萨斯州的一家生物样本存储设施** FTRE表示，此次收购将增强其内部生物分析能力，并扩大其在北美地区的早期临床研究能力** Worldwide表示，此次交易将使其能够将投资重点放在快速增长的肿瘤学、神经科学、内科及罕见病领域的后期业务上** 该交易预计将在获得监管机构和许可批准后完成** 截至上一交易日收盘，该股年初至今累计上涨约3%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}